2nd Edition of the Amazon Bestseller: Biotechnology Valuation & Investing
The selection of biotech stocks for investment is more difficult compared with the selection of other stocks and industries that possess historical data, since biotechnology is a recently new science. In the first edition of this book, we described the crucial parameters for the valuation of an early stage biotech company without a drug in the market.
In the 2nd edition, we analyze novel financial models that can value stocks of biotech companies with products in the market or products under development (in pre-clinical and clinical studies). All these parameters should be helpful to potential new investors when creating a stock portfolio that includes highly promising biotech companies.
Book is available on Amazon.